EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Production of Filovirus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus for Study of Filovirus Entry Mechanisms



Production of Filovirus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus for Study of Filovirus Entry Mechanisms



Methods in Molecular Biology 1628: 53-63



Members of the family Filoviridae are filamentous, enveloped, and nonsegmented negative-stranded RNA viruses that can cause severe hemorrhagic disease in humans and nonhuman primates with high mortality rates. Current efforts to analyze the structure and biology of these viruses as well as the development of antivirals have been hindered by the necessity of biosafety level 4 containment (BSL4). Here, we outline how to produce and work with Ebola virus glycoprotein bearing vesicular stomatitis virus (VSV) pseudovirions. These pseudovirions can be safely used to evaluate early steps of the filovirus life cycle without need for BSL4 containment. Virus gene expression in the transduced cells is easy to assess since the pseudovirions encode a reporter gene in place of the VSV G glycoprotein gene. Adoption of VSV for use as a pseudovirion system for filovirus GP has significantly expanded access for researchers to study specific aspects of the viral life cycle outside of BSL4 containment and has allowed substantial growth of filovirus research.

(PDF emailed within 0-6 h: $19.90)

Accession: 060136683

Download citation: RISBibTeXText

PMID: 28573610

DOI: 10.1007/978-1-4939-7116-9_4



Related references

Vesicular Stomatitis Virus-Based Vaccines for Prophylaxis and Treatment of Filovirus Infections. Journal of Bioterrorism & Biodefense S1(4): -, 2012

Production of vesicular stomatitis virus G glycoprotein (VSV-G) pseudotyped retroviral vectors. Current Protocols in Human Genetics Chapter 12: Unit 12.7-Unit 12.7, 2008

Stat1-Deficient Mice Are Not an Appropriate Model for Efficacy Testing of Recombinant Vesicular Stomatitis Virus-Based Filovirus Vaccines. Journal of Infectious Diseases 212 Suppl 2: S404-S409, 2015

Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates. Plos Neglected Tropical Diseases 6(3): E1567-E1567, 2012

Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. Methods 12(4): 337-342, 1997

Cholesterol Supplementation During Production Increases the Infectivity of Retroviral and Lentiviral Vectors Pseudotyped with the Vesicular Stomatitis Virus Glycoprotein (VSV-G). Biochemical Engineering Journal 44(2-3): 199-207, 2010

Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors. Journal of Virology 83(19): 10176-10186, 2009

Vesicular stomatitis virus glycoprotein- and Venezuelan equine encephalitis virus-derived glycoprotein-pseudotyped lentivirus vectors differentially transduce corneal endothelium, trabecular meshwork, and human photoreceptors. Human Gene Therapy 25(1): 50-62, 2014

Pseudotyped vesicular stomatitis virus for analysis of virus entry mediated by SARS coronavirus spike proteins. Methods in Molecular Biology 454: 331-338, 2008

Retro-transduction by virus pseudotyped with glycoprotein of vesicular stomatitis virus. Virology 362(1): 131-138, 2007

Mechanisms of Filovirus Entry. Current Topics in Microbiology and Immunology 411: 323-352, 2017

Neutralization of pseudotyped vesicular stomatitis virus expressing hepatitis C virus envelope glycoprotein 1 or 2 by serum from patients. Journal of Infectious Diseases 185(8): 1165-1169, 2002

Hepatocyte-specific gene expression by baculovirus pseudotyped with vesicular stomatitis virus envelope glycoprotein. Biochemical and Biophysical Research Communications 289(2): 444-450, 2001

Transduction of Schistosoma mansoni by vesicular stomatitis virus glycoprotein-pseudotyped Moloney murine leukemia retrovirus. Experimental Parasitology 112(4): 209-220, 2006

Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry. Journal of Virology 74(5): 2481-2487, 2000